跳至主要内容
临床试验/NCT04905628
NCT04905628Unknown不适用

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

DexCom, Inc.5 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年7月8日最近更新:
适应症

试验速览

阶段
不适用
发起方
DexCom, Inc.
入组人数
100
试验地点
5
主要终点
Dexcom Continuous Glucose Monitoring (CGM) System Performance

研究概览

简要总结

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Confirmed pregnancy
  • Diagnosis of Gestational Diabetes (GDM), Type 1 Diabetes Mellitus (T1DM), or Type 2 Diabetes Mellitus (T2DM)
  • Willing to wear up to the required number of Systems for the total duration of study wear
  • Able to follow study procedures;
  • Able to speak, read, and write in English or Spanish.

排除标准

  • Extensive skin changes/diseases that preclude wearing the required number of Systems at the proposed wear sites
  • Known allergy to medical-grade adhesives
  • Hematocrit outside specification
  • Prescribed drugs for treatment of pre-term labor or experiencing high-risk pregnancy complications during current pregnancy
  • Currently receiving dialysis treatment or planning to receive dialysis during the sensor wear period
  • Currently using Hydroxyurea for treatment
  • Require a Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, or diathermy during the sensor wear period

结局指标

主要结局

Dexcom Continuous Glucose Monitoring (CGM) System Performance

时间窗: 10 Days

The Dexcom Continuous Glucose Monitoring (CGM) System performance will be assessed compared to Yellow Springs Instrument (YSI) comparator venous plasma measurements

次要结局

  • System Related Adverse Device Effects(10 Days)

研究者

发起方
DexCom, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验